These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 18815449

  • 21. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J, Svensson SE.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [Abstract] [Full Text] [Related]

  • 22. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 23. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD.
    Am J Cardiol; 2011 Nov 01; 108(9):1316-21. PubMed ID: 21871590
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S, Webb MC, Price CP, John RI, Abbas NA, Lamb EJ.
    Nephrol Dial Transplant; 2008 Nov 01; 23(11):3546-53. PubMed ID: 18562472
    [Abstract] [Full Text] [Related]

  • 25. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R.
    Clin Endocrinol (Oxf); 2007 Aug 01; 67(2):202-7. PubMed ID: 17547691
    [Abstract] [Full Text] [Related]

  • 26. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I, Belhadj R, Mohseni A, Bazdeh L, Drissa H, Elyounsi F, Abdallah TB, Abdelmoula J, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Mar 01; 21(2):262-8. PubMed ID: 20228511
    [Abstract] [Full Text] [Related]

  • 27. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Mar 01; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 28. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 01; 11(6):429-32. PubMed ID: 19558803
    [Abstract] [Full Text] [Related]

  • 29. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V.
    Am J Hypertens; 2008 Jul 01; 21(7):820-5. PubMed ID: 18443568
    [Abstract] [Full Text] [Related]

  • 30. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
    Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK.
    Diabetes Res Clin Pract; 2007 Sep 01; 77 Suppl 1():S238-42. PubMed ID: 17490778
    [Abstract] [Full Text] [Related]

  • 31. N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.
    Hildebrandt P, Boesen M, Olsen M, Wachtell K, Groenning B.
    Eur J Heart Fail; 2004 Mar 15; 6(3):313-7. PubMed ID: 14987582
    [Abstract] [Full Text] [Related]

  • 32. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

  • 33. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.
    Coron Artery Dis; 2009 May 15; 20(3):225-9. PubMed ID: 19387249
    [Abstract] [Full Text] [Related]

  • 34. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction.
    Giallauria F, Lucci R, De Lorenzo A, D'Agostino M, Del Forno D, Vigorito C.
    Age Ageing; 2006 Nov 15; 35(6):601-7. PubMed ID: 16951263
    [Abstract] [Full Text] [Related]

  • 35. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul 15; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN, Val-HeFT Investigators.
    J Am Coll Cardiol; 2008 Sep 16; 52(12):997-1003. PubMed ID: 18786480
    [Abstract] [Full Text] [Related]

  • 40. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.
    J Cardiovasc Med (Hagerstown); 2009 Mar 16; 10(3):238-44. PubMed ID: 19262210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.